Cargando…
Commentary: Donepezil enhances understanding of degraded speech in Alzheimer's disease
Autores principales: | Campbell, Tom A., Marsh, John E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6053516/ https://www.ncbi.nlm.nih.gov/pubmed/30057546 http://dx.doi.org/10.3389/fnagi.2018.00197 |
Ejemplares similares
-
Donepezil enhances understanding of degraded speech in Alzheimer's disease
por: Hardy, Chris J. D., et al.
Publicado: (2017) -
A Network Pharmacology Based Research on the Mechanism of Donepezil in Treating Alzheimer's Disease
por: Liu, Lihua, et al.
Publicado: (2022) -
Efficacy of THN201, a Combination of Donepezil and Mefloquine, to Reverse Neurocognitive Deficits in Alzheimer’s Disease
por: Droguerre, Marine, et al.
Publicado: (2020) -
Transdermal donepezil on the treatment of Alzheimer’s disease
por: Sozio, Piera, et al.
Publicado: (2012) -
Meta-Analysis of Randomized Controlled Trials on the Efficacy and Safety of Donepezil, Galantamine, Rivastigmine, and Memantine for the Treatment of Alzheimer’s Disease
por: Li, Dan-Dan, et al.
Publicado: (2019)